An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS
Science Advances · 2025
DOI: 10.1126/sciadv.adt4814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Jacob Neeves und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Cytoplasm, Alternative Splicing, PTB-Associated Splicing Factor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Splicing factor proline- and glutamine-rich (SFPQ) is an RNA binding protein that broadly regulates RNA metabolism. Although its nuclear roles are well studied, evidence of SFPQ’s cytoplasmic functionality is emerging. Altered expression and nuclear-to-cytoplasmic redistribution of SFPQ have been recognized in amyotrophic lateral sclerosis (ALS) pathology, yet the mechanistic bases for these phenomena remain undetermined. We identified altered SFPQ splicing in ALS, increasing the expression of an alternative mRNA isoform lacking a nuclear localization sequence, which we termed “ altSFPQ .” We find that altSFPQ mRNA contributes to SFPQ autoregulation and is highly unstable yet exhibits context-specific translation with cytoplasm-predominant localization. Notably, reduced canonical SFPQ coincides with increased altSFPQ transcript expression in familial and sporadic ALS models, providing a mechanistic basis for SFPQ nuclear-to-cytoplasmic redistribution in patients with ALS. Last, we observe that the altSFPQ protein has reduced phase separation potential and differential protein binding compared to its canonical counterpart, providing insight into its mechanistic relevance to physiology and ALS pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
- The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
- UK Dementia Research Institute at King's College London, London, UK.
- Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
- Functional Proteomics team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
- UK Dementia Research Institute at University College London, London, UK.
ORCID-Profile: Jacob Neeves, Marija Petrić Howe, Oliver J Ziff, Beth Callaghan, Daniel Jutzi, Koustav Pal, Jyoti Choudhary, Adrian M Isaacs, C Frank Bennett, Marc-David Ruepp, Rickie Patani
Förderung
- Wellcome Trust
Zitieren
APA
Neeves, J., Petrić Howe, M., Ziff, O. J., Callaghan, B., Jutzi, D., Pal, K., Roumeliotis, T. I., Choudhary, J., Isaacs, A. M., Rigo, F., Bennett, C. F., Ruepp, M. D., & Patani, R. (2025). An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS. Science Advances. https://doi.org/10.1126/sciadv.adt4814
Vancouver
Neeves J, Petrić Howe M, Ziff OJ, Callaghan B, Jutzi D, Pal K, et al. An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS. Science Advances. 2025. doi:10.1126/sciadv.adt4814
BibTeX
@article{Neeves2025,
author = {Neeves, Jacob and Petrić Howe, Marija and Ziff, Oliver J and Callaghan, Beth and Jutzi, Daniel and Pal, Koustav and Roumeliotis, Theodoros I and Choudhary, Jyoti and Isaacs, Adrian M and Rigo, Frank and Bennett, C Frank and Ruepp, Marc-David and Patani, Rickie},
title = {An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt4814}
}
EUVIMED